Quantitative proteomics of aqueous and vitreous fluid from patients with idiopathic epiretinal membranes

Experimental Eye Research

Volumn 108, Issue , 2013, Pages 48-58

  Pollreisz, Andreas ^a   Funk, Marion ^a   Breitwieser, Florian P ^b   Parapatics, Katja ^a,b   Sacu, Stefan ^a   Georgopoulos, Michael ^a   Dunavoelgyi, Roman ^a   Zlabinger, Gerhard J ^a   Colinge, Jacques ^b   Bennett, Keiryn L ^b   Schmidt Erfurth, Ursula ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

Epiretinal membranes; Mass spectrometry; Ocular fluids; Quantitative proteomics

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; FLT3 LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12P40; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR AA; PLATELET DERIVED GROWTH FACTOR BB; PROTEOME; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AQUEOUS HUMOR; ARTICLE; CELL ADHESION; EPIRETINAL MEMBRANE; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; IDIOPATHIC EPIRETINAL MEMBRANE; LIQUID CHROMATOGRAPHY MASS SPECTROMETRY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEOMICS; VITREOUS BODY;

AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; AUSTRIA; BIOLOGICAL MARKERS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; DATABASES, PROTEIN; EPIRETINAL MEMBRANE; EYE PROTEINS; HUMANS; MIDDLE AGED; PEPTIDE MAPPING; PROSPECTIVE STUDIES; PROTEOMICS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; VITREOUS BODY;

EID: 84872477150     PISSN: 00144835     EISSN: 10960007     Source Type: Journal    
DOI: 10.1016/j.exer.2012.11.010     Document Type: Article

References (34)

1. Bennett K.L., Funk M., Tschernutter M., Breitwieser F.P., Planyavsky M., Mohien C.U., Muller A., Trajanoski Z., Colinge J., Superti-Furga G., Schmidt-Erfurth U. Proteomic analysis of human cataract aqueous humour: comparison of one-dimensional gel LCMS with two-dimensional LCMS of unlabelled and iTRAQ(R)-labelled specimens. J. Proteomics 2011, 74:151-166.
2. Breitwieser F.P., Muller A., Dayon L., Kocher T., Hainard A., Pichler P., Schmidt-Erfurth U., Superti-Furga G., Sanchez J.C., Mechtler K., Bennett K.L., Colinge J. General statistical modeling of data from protein relative expression isobaric tags. J. Proteome Res. 2011, 10:2758-2766.
3. Cassidy L., Barry P., Shaw C., Duffy J., Kennedy S. Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders. Br. J. Ophthalmol. 1998, 82:181-185.
4. Chowdhury U.R., Madden B.J., Charlesworth M.C., Fautsch M.P. Proteome analysis of human aqueous humor. Invest. Ophthalmol. Vis. Sci. 2010, 51:4921-4931.
5. Colinge J., Masselot A., Giron M., Dessingy T., Magnin J. OLAV: towards high-throughput tandem mass spectrometry data identification. Proteomics 2003, 3:1454-1463.
6. de Souza G.A., Godoy L.M., Mann M. Identification of 491 proteins in the tear fluid proteome reveals a large number of proteases and protease inhibitors. Genome Biol. 2006, 7:R72.
7. Funk M., Karl D., Georgopoulos M., Benesch T., Sacu S., Polak K., Zlabinger G.J., Schmidt-Erfurth U. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab. Ophthalmology 2009, 116:2393-2399.
8. Funk M., Kriechbaum K., Prager F., Benesch T., Georgopoulos M., Zlabinger G.J., Schmidt-Erfurth U. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab. Invest. Ophthalmol. Vis. Sci. 2009, 50:1025-1032.
9. Funk M., Schmidinger G., Maar N., Bolz M., Benesch T., Zlabinger G.J., Schmidt-Erfurth U.M. Angiogenic and inflammatory markers in the intraocular fluid of eyes with diabetic macular edema and influence of therapy with bevacizumab. Retina 2010, 30:1412-1419.
10. Gerber S.A., Rush J., Stemman O., Kirschner M.W., Gygi S.P. Absolute quantification of proteins and phosphoproteins from cell lysates by tandem MS. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6940-6945.
11. Gilar M., Olivova P., Daly A.E., Gebler J.C. Two-dimensional separation of peptides using RP-RP-HPLC system with different pH in first and second separation dimensions. J. Sep. Sci. 2005, 28:1694-1703.
12. Harada C., Harada T., Mitamura Y., Quah H.M., Ohtsuka K., Kotake S., Ohno S., Wada K., Takeuchi S., Tanaka K. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy. Mol. Vis. 2004, 10:31-36.
13. Harada C., Mitamura Y., Harada T. The role of cytokines and trophic factors in epiretinal membranes: involvement of signal transduction in glial cells. Prog. Retin. Eye Res. 2006, 25:149-164.
14. Kim T., Kim S.J., Kim K., Kang U.B., Lee C., Park K.S., Yu H.G., Kim Y. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients. Proteomics 2007, 7:4203-4215.
15. Koch A.E., Halloran M.M., Haskell C.J., Shah M.R., Polverini P.J. Angiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1. Nature 1995, 376:517-519.
16. Limb G.A., Chignell A.H., Green W., LeRoy F., Dumonde D.C. Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br. J. Ophthalmol. 1996, 80:168-173.
17. Mansour A.M., Chess J., Henkind P. Fibrinogen-induced vitreous membranes. Ophthalmic Res. 1987, 19:164-169.
18. McLeod D., Hiscott P.S., Grierson I. Age-related cellular proliferation at the vitreoretinal juncture. Eye 1987, 1:263-281.
19. Minchiotti S., Stampachiacchiere B., Micera A., Lambiase A., Ripandelli G., Billi B., Bonini S. Human idiopathic epiretinal membranes express NGF and NGF receptors. Retina 2008, 28:628-637.
20. Mori K., Gehlbach P., Ando A., Dyer G., Lipinsky E., Chaudhry A.G., Hackett S.F., Campochiaro P.A. Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy. Invest. Ophthalmol. Vis. Sci. 2002, 43:2001-2006.
21. Nam D.H., Oh J., Roh J.H., Huh K. Different expression of vascular endothelial growth factor and pigment epithelium-derived factor between diabetic and non-diabetic epiretinal membranes. Ophthalmologica 2009, 223:188-191.
22. Ong S.E., Blagoev B., Kratchmarova I., Kristensen D.B., Steen H., Pandey A., Mann M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1:376-386.
23. Ouchi M., West K., Crabb J.W., Kinoshita S., Kamei M. Proteomic analysis of vitreous from diabetic macular edema. Exp. Eye Res. 2005, 81:176-182.
24. Ross P.L., Huang Y.N., Marchese J.N., Williamson B., Parker K., Hattan S., Khainovski N., Pillai S., Dey S., Daniels S., Purkayastha S., Juhasz P., Martin S., Bartlet-Jones M., He F., Jacobson A., Pappin D.J. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3:1154-1169.
25. Sivalingam A., Kenney J., Brown G.C., Benson W.E., Donoso L. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch. Ophthalmol. 1990, 108:869-872.
26. Smiddy W.E., Maguire A.M., Green W.R., Michels R.G., de la Cruz Z., Enger C., Jaeger M., Rice T.A. Idiopathic epiretinal membranes. Ultrastructural characteristics and clinicopathologic correlation. Ophthalmology 1989, 96:811-820.
27. Srinivasan S., Thangavelu M., Zhang L., Green K.B., Nichols K.K. iTRAQ quantitative proteomics in the analysis of tears in dry eye patients. Invest. Ophthalmol. Vis. Sci. 2012, 53:5052-5059.
28. Theocharis I. Fibrinogen and rhegmatogenous retinal detachment: a pilot prospective study. Clin. Ophthalmol. 2010, 4:73-76.
29. Thompson A., Schafer J., Kuhn K., Kienle S., Schwarz J., Schmidt G., Neumann T., Johnstone R., Mohammed A.K., Hamon C. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal. Chem. 2003, 75:1895-1904.
30. Ubaida Mohien C., Hartler J., Breitwieser F., Rix U., Remsing Rix L., Winter G.E., Thallinger G.G., Bennett K.L., Superti-Furga G., Trajanoski Z., Colinge J. MASPECTRAS 2: an integration and analysis platform for proteomic data. Proteomics 2010, 10:2719-2722.
31. Watanabe D., Suzuma K., Suzuma I., Ohashi H., Ojima T., Kurimoto M., Murakami T., Kimura T., Takagi H. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy. Am. J. Ophthalmol. 2005, 139:476-481.
32. Wiener M.C., Sachs J.R., Deyanova E.G., Yates N.A. Differential mass spectrometry: a label-free LC-MS method for finding significant differences in complex peptide and protein mixtures. Anal. Chem. 2004, 76:6085-6096.
33. Yu J., Liu F., Cui S.J., Liu Y., Song Z.Y., Cao H., Chen F.E., Wang W.J., Sun T., Wang F. Vitreous proteomic analysis of proliferative vitreoretinopathy. Proteomics 2008, 8:3667-3678.
34. Zybailov B., Mosley A.L., Sardiu M.E., Coleman M.K., Florens L., Washburn M.P. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J. Proteome Res. 2006, 5:2339-2347.